Bone Biologics Corp (BBLG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bone Biologics Corp (BBLG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3049
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. The company develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers Nell-1/TCP fusion device, which is a single dose vial of Nell-1 recombinant protein freeze dried onto tricalcium phosphate and demineralized bone putty. The company’s technology has application in spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicines. It collaborates with manufacturing organizations to develop its products. The company markets its products domestic and internationally. Bone Biologics is headquartered in Burlington, Massachusetts, the US.

Bone Biologics Corp (BBLG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Bone Biologics Raises USD5 Million in Venture Financing 11
Merger 12
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 12
Equity Offering 13
Bone Biologics Raises USD3.9 Million in Private Placement of Shares 13
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 14
Debt Offering 15
Bone Biologics Raises USD2 Million in Private Placement of 8.5% Notes Due 2019 15
Bone Biologics Corp – Key Competitors 16
Bone Biologics Corp – Key Employees 17
Bone Biologics Corp – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Aug 03, 2017: Bone Biologics Announces Appointment of Bret Hankey to Company’s Board of Director 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Bone Biologics Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bone Biologics Raises USD5 Million in Venture Financing 11
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 12
Bone Biologics Raises USD3.9 Million in Private Placement of Shares 13
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 14
Bone Biologics Raises USD2 Million in Private Placement of 8.5% Notes Due 2019 15
Bone Biologics Corp, Key Competitors 16
Bone Biologics Corp, Key Employees 17

List of Figures
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Bone Biologics Corp (BBLG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bianor Holding AD Sofia (5BI):企業の財務・戦略的SWOT分析
    Bianor Holding AD Sofia (5BI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Miracor Medical Systems GmbH:製品パイプライン分析
    Summary Miracor Medical Systems GmbH (Miracor Medical) is a medical device company that develops and commercializes pressure-controlled intermittent coronary sinus occlusions. The company offers products for continuous monitoring of coronary sinus pressure dynamics. It offers impulse console and imp …
  • Altra Industrial Motion Corp (AIMC):企業の財務・戦略的SWOT分析
    Summary Altra Industrial Motion Corp (Altra Industries), formerly Altra Holdings Inc is an industrial equipment company that designs and manufactures power transmission and motion control products. The company offers products such as electric clutches and brakes, couplings, heavy duty clutches and b …
  • Histogenics Corp (HSGX):企業の財務・戦略的SWOT分析
    Summary Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient’s own cartilage cells which are harvested from non-weigh …
  • AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析
    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ARMO Biosciences Inc (ARMO):製薬・医療:M&Aディール及び事業提携情報
    Summary ARMO Biosciences Inc (ARMO Biosciences) is an immuno-oncology company that develops tumors treatment drugs. Its pipeline drug candidates include AM0010, AM0015, AM0012, AM0003 and AM0001. ARMO Biosciences’s lead immunotherapy AM0010 is along-acting form of recombinant human Interleukin 10 (I …
  • Automatic Data Processing, Inc.:企業の戦略・SWOT・財務情報
    Automatic Data Processing, Inc. - Strategy, SWOT and Corporate Finance Report Summary Automatic Data Processing, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Feilo Sylvania Europe Ltd:企業の戦略的SWOT分析
    Feilo Sylvania Europe Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Randstad Holding nv:企業の戦略・SWOT・財務分析
    Randstad Holding nv - Strategy, SWOT and Corporate Finance Report Summary Randstad Holding nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Fukuda Denshi Co Ltd (6960):医療機器:M&Aディール及び事業提携情報
    Summary Fukuda Denshi Co Ltd (Fukuda Denshi) is a medical device company, which develops, manufactures, and commercializes medical equipment including cardiology, patient monitoring, vascular screening and ultrasound systems. The company’s product portfolio includes electrocardiographs, stress tests …
  • iCardiac Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary iCardiac Technologies Inc (iCardiac) is a provider of medical laboratory services. The company’s services portfolio include cardiac safety and respiratory services, cardiac safety assessment methodology, clinical trials, electrophysiology, drug development, regulatory services, protocol deve …
  • Dentsply Sirona Inc (XRAY):企業の財務・戦略的SWOT分析
    Dentsply Sirona Inc (XRAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Alliance Data Systems Corporation:企業の戦略・SWOT・財務情報
    Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Enlivant Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Enlivant Inc (Enlivant) is an assisted living facilities provider that offers senior living residence services. The center provides senior housing options, choosing assisted living and short term stay services. It also provides attentive and individualized care services. Enlivant offers assi …
  • Noble Energy Inc (NBL)-石油・ガス分野:企業M&A・提携分析
    Summary Noble Energy, Inc. (Noble Energy) is an independent energy company that explores for and produces crude oil, natural gas and natural gas liquids (NGLs). The company’s portfolio includes both US unconventional and global offshore conventional assets in various countries. Noble Energy has oper …
  • Loral Space & Communications Inc. (LORL):企業の財務・戦略的SWOT分析
    Loral Space & Communications Inc. (LORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • ReproCELL Inc (4978):企業の財務・戦略的SWOT分析
    Summary ReproCELL Inc (ReproCELL) is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation materials, and cell and biorepository. Its research reagent products include hES iPSC culture reagents …
  • PT Tempo Scan Pacific Tbk (TSPC):企業の財務・戦略的SWOT分析
    PT Tempo Scan Pacific Tbk (TSPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • EnWave Corp (ENW):企業の財務・戦略的SWOT分析
    EnWave Corp (ENW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Venari Resources LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Venari Resources LLC (Venari Resources) is an offshore oil and gas production and exploration company that discovers, develops, explores, and produces oil and gas from its deep water blocks located in the Gulf of Mexico. The company owns and operates in drilling wells and discovering barrels …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆